Teva says it’s eyeing a debt-cutting sale of its cancer meds chelfand Wed, 04/26/2017 – 10:45 More: Teva says it's eyeing a debt-cutting sale of its cancer meds Source: fierce
read moreuniQure’s investigational gene therapy for patients with the blood clotting disorder haemophilia B has been awarded PRIME status by European regulators, potentially placing the treatment on a faster path to approval. More: UniQure’s haemophilia B therapy picks up PRIME status
read moreThe MS Trust has announced that Leicester and Bradford are the first sites chosen for its multiple sclerosis specialist nurse funding programme, which aims to help improve access to targeted support in areas of the country where there is the
read moreEuropean regulators have now issued a full approval for AstraZeneca’s lung cancer drug Tagrisso, having awarded the drug a conditional approval in February last year. More: EU issues full approval for AZ’ Tagrisso Source: News
read morePatients with plaque psoriasis should be able to get routine access to Eli Lilly’s Taltz on the NHS within the next three months if they meet certain eligibility criteria. More: NICE green light for Lilly’s psoriasis drug Source: News
read moreJAMA More: Nocturnal polyuria drug approved Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals